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1. ABSTRACT  34 
 35 
Background: Traumatic spinal cord injuries (TSCI) are a neurological condition associated 36 
with reduced well-being, increased morbidity and reductions in life expectancy. Estimates of 37 
all-cause and cause-specific mortality can aid in identifying targets for prevention and 38 
management of contributors for premature mortality.  39 
 40 
Objectives: To compare all-cause and cause-specific rates of mortality to that of the Swiss 41 
general population; to identify differentials in risk of cause-specific mortality according to 42 
lesion characteristics. 43 
 44 
Methods: All-cause and cause-specific standardized mortality ratios (SMRs) were calculated 45 
using data from the Swiss Spinal Cord Injury (SwiSCI) cohort study. Cause-specific subhazard 46 
ratios (sHRs) were estimated within a competing risk framework using flexible parametric 47 
survival models. 48 
 49 
Results: Between 1990 and 2011, 2’492 persons sustained a TSCI, of which 379 died. Persons 50 
with TSCI had a mortality rate more than two times higher than that of the Swiss general 51 
population (SMR=2.32; 95% CI=2.10-2.56). Tetraplegic lesions were associated with an 52 
increased risk of mortality due to respiratory and cardiovascular diseases, infections, and 53 
accidents. Cause-specific SMRs were notably elevated for SCI-related conditions such as 54 
urinary tract infections and septicemia. 55 
 56 
Conclusions: Elevated SMRs due to cardiovascular disease, urinary tract infections and 57 
septicemia-related mortality suggest the need for innovation when managing associated 58 
secondary health conditions. 59 
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2. Introduction 60 
In a recent re-evaluation of the WHO Global Burden of Disease study [1], neurological 61 
diseases were identified as the leading contributor to the global burden [2]. With overall 62 
global aging, the number of people affected with neurological diseases is only expected to 63 
augment, regardless of notable reductions in age-standardized rates [2]. Traumatic spinal 64 
cord injuries (TSCIs), comprised within the assemblage of neurological diseases, are a 65 
disabling condition associated with reduced functioning, and quality of life, increased 66 
morbidity, and reductions in life expectancy. In comparison to the general population, 67 
persons with TSCI have a roughly 2.5 times greater risk of mortality (standardized mortality 68 
ratio [SMR]=2.5, 95% confidence interval [CI]=1.9-3.2) [3]. This burden of mortality is similar 69 
to what has been estimated for other chronic neurological conditions such as multiple 70 
sclerosis (MS) (SMR=2.8, 95% CI=2.7-2.9) [4] or traumatic brain injury (TBI) (SMR=2.3; 95% 71 
CI=2.1-2.4) [5].  72 
Reductions in premature mortality associated with neurological diseases would aid in 73 
reduction of global burden of disease. Unfortunately, most research on long-term mortality 74 
risk post-SCI have found little to no improvements in recent decades [3], and although 75 
persons with SCI have the potential for a life expectancy similar to that of the general 76 
population, within-population and between-country discrepancies in mortality and survival 77 
estimates exist [3,6]. Importantly, these discrepancies reflect the influence of SCI 78 
characteristics and health systems on risk of mortality, and can thereby be exploited to 79 
identify targeted interventions and areas for innovation. To this aim, estimates of all-cause 80 
and cause-specific mortality can aid in identifying targets for prevention and management of 81 
contributors for premature mortality. Furthermore, cause-specific mortality comparisons to 82 
the general population can help with benchmarking to identify target areas for health 83 
system improvement. The purpose of this study is to thereby provide cause-specific 84 
mortality estimates within the SCI population as well as in comparison to the general 85 
population. 86 
 87 
3. Methods 88 
Study population 89 
The present study employs data collected in the Swiss Spinal Cord Injury (SwiSCI) cohort on 90 
incident cases of TSCI admitted to a specialized rehabilitation facility between 1990 and 91 
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2011 [7]. Information on cause of deaths (CoDs) was obtained through probabilistic linkage 92 
[8] with the Swiss National Cohort (SNC) based on date of birth, date of death (when 93 
available), geocoded address, age and sex; applying a similar methodology as that used in 94 
previous studies [9,10]. New cases of SCI admitted to an active specialized rehabilitation 95 
facility within Switzerland were eligible for linkage. Of the original 6’162 cases, including 96 
incident cases of non-traumatic and traumatic SCI from pre-1960, 85.5% were linked 97 
(N=5’266) to the SNC data. A weight was created corresponding to the likelihood of a correct 98 
match for persons within the SwiSCI dataset with multiple potential matches (21.6%). 99 
Records with the highest weight were used in analyses, secondary matches – alternative 100 
links – were included in a sensitivity analysis.  101 
 102 
Causes of death  103 
For each linked mortality record, up to five causes or contributing causes of death were 104 
recorded using ICD-8 (until 1994) and ICD-10 coding (1995 and later): the underlying CoD; 105 
the initial cause of disease; the consecutive disease; and two concomitant diseases. Previous 106 
studies using CoD information have used the underlying cause of death for analyses, which is 107 
defined as the disease or injury that initiated events leading to death, including chronic 108 
conditions [11]. A hierarchical approach was used to identify the CoD relevant for cause-109 
specific mortality analyses and the calculation of SMRs, as implemented in previous studies 110 
[12]. This approach skips over CoDs related to an external injury code (e.g., sequelae from 111 
traffic accident) or SCI-related ICD code to identify a CoD relevant for secondary prevention. 112 
For example, when using this hierarchical approach, a CoD coded as „paraplegia/tetraplegia“ 113 
or „external injury“ at the primary, secondary, or tertiary level was ignored until a code 114 
unrelated to SCI was identified, if available.  115 
 116 
A categorical variable was created to group causes of death into six broad categories based 117 
on expert opinion, previous literature [13], data availability, as well as identifying meaningful 118 
groups for targeted prevention. These groups include: respiratory diseases (ICD-10 119 
codes=J30-J99 – excluding respiratory infections); cardiovascular disease (I00-I99); 120 
neoplasms (C00-D49); infections (including respiratory and urinary tract infections (UTI): 121 
A00-B99, J00-J22, N390-392); accidents (S00-Y99, excluding X60-X84); and all other causes of 122 
mortality.  123 
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 124 
Statistical analysis 125 
Standardized mortality ratios (SMRs) were calculated using mortality rates for the general 126 
population (GP) (obtained through the SNC) stratified by age, sex, year, and CoD. Flexible 127 
parametric models within a competing-risk framework were used to estimate cause-specific 128 
subhazard ratios (sHRs) [14]. Separate baseline hazards were estimated for circulatory and 129 
respiratory diseases, as well as accidents and all other causes to allow for potential time-130 
varying effects according to cause of death. Attained age, lesion level and completeness 131 
were assumed to have an influence on cause-specific mortality, and were therefore 132 
interacted with each CoD to allow for the effect of these covariates to vary according to CoD. 133 
Attained age at death or study end was accomplished with data splitting techniques.  134 
 135 
Given the potential for coding inaccuracies in CoD statistics, two plausible alternative coding 136 
scenarios were implemented to evaluate the robustness of results:  137 
- Sensitivity analysis 1: Re-calculation of SMRs using the original underlying CoD, not 138 
applying hierarchical coding scheme (Supplementary Table 1) 139 
- Sensitivity analysis 2: Competing-risk analysis for pre-identified SCI-related causes of 140 
interest (i.e., respiratory infections and UTI/renal failure) recorded anywhere on death 141 
certificate (i.e., underlying CoD, initial disease, consecutive, or concomitant) 142 
(Supplementary Table 2 and 3). 143 
 144 
All analyses were carried out using Stata version 14.2 [15]. 145 
4. Results 146 
Summary statistics  147 
Between 1990 and 2011, 2’492 persons were admitted for first rehabilitation within a 148 
specialized rehabilitation center; of which, 379 had a known date of death, contributing to 149 
20’099.9 years of follow-up time. Cause of death information was available for 335 cases. 150 
Excluding deaths due to accident- or SCI-related ICD-10 codes, cardiac disease (11.9%), 151 
ischemic heart disease (10.1%), neoplasms (8.1%), and suicide (6.3%) were the most 152 
commonly recorded CoDs (Table 1). Accidents were less frequently recorded when excluding 153 
deaths that occurred less than one year post-injury (Table 1).  154 
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The overall mortality rate for persons with TSCI was more than two times higher than 155 
that of the Swiss GP (SMR=2.32; 95% CI=2.10-2.56) (Table 2). SMRs were elevated for 156 
women (SMR=2.61; 95% CI=2.18-3.13) and tetraplegics (SMR=2.65; 95% CI=2.31-3.04) (Table 157 
2). The synergistic influence of lesion level and completeness on mortality rates was 158 
evidenced in that the mortality rate for incomplete paraplegics was 1.6 times that of the GP 159 
(SMR=1.64; 95% CI=1.32-2.03), while for complete tetraplegics, the difference was 8.5 times 160 
higher than that of the GP (SMR=8.49; 95% CI=6.55-11.01) (Table 2). 161 
 162 
Cause-specific mortality 163 
Cause-specific SMRs are presented in Table 3. Relative to the GP, persons with TSCI 164 
experienced the highest burden of mortality due to septicemia-related deaths (SMR=19.71; 165 
95% CI=9.40-41.35) (Table 3). With the exception of a few specific causes of death (e.g., 166 
chronic obstructive pulmonary disease and neoplasms), mortality rates for persons with SCI 167 
were higher overall in comparison with the GP (Table 3). For example, persons with SCI 168 
experienced mortality rates due to cardiovascular disease 2.7 times greater than that of the 169 
general population (SMR=2.67, 95% CI=2.23-3.19; including cardiac disease, ischemic heart 170 
disease, and all circulatory diseases). Cause-specific SMRs further varied according to SCI 171 
characteristics (Table 4). When not applying a hierarchical coding scheme, SMRs for 172 
accidents and nervous system-related diseases augmented, while SMRs estimated for 173 
respiratory infections, other respiratory and other circulatory diseases diminished and were 174 
no longer different than mortality rates experienced by the GP (Supplementary Table 1).  175 
Subhazard ratios are presented in Table 5.  Regardless of specific CoD, sHRs were highest 176 
for the oldest age group (60 years and older) (Table 5). Following adjustment, tetraplegic 177 
lesions were associated with an increased risk of mortality due to respiratory and 178 
cardiovascular diseases, infections, and accidents (Table 5). Complete lesions were also 179 
associated with an elevated risk for mortality due to respiratory diseases and accidents 180 
(Table 5). With the exception of age, there was no difference in risk of mortality due to 181 
neoplasms or other causes according to lesion characteristics. In a separate analysis on risk 182 
of mortality due to respiratory infections, sHRs were elevated for both for tetraplegic and 183 
complete lesions (Supplementary Table 2). This relationship remained when including all 184 
individuals with a respiratory infection coded on the death certificate, regardless of the 185 
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position (Supplementary Table 2). No differential in risk of mortality due to UTI/renal failure 186 
was identified according to lesion characteristics (Supplementary Table 3).  187 
 188 
5. Discussion 189 
Persons with a TSCI have a more than doubled rate of mortality in comparison with the GP, 190 
with augmenting disparities associated with increasing severity. Furthermore, cause-specific 191 
SMRs as well as risk for cause-specific mortality varied according to lesion level and 192 
completeness, with tetraplegic and complete lesions exhibiting a higher risk in mortality due 193 
to respiratory and cardiovascular disease, infections, and accidents in comparison with 194 
paraplegic and incomplete lesions.  195 
Cardiovascular diseases, suicide, and systemic infections are the leading causes of death 196 
in the present study population when excluding accident and nervous system-related ICD 197 
codes. In comparison with previous studies, some discrepancies in leading causes of death 198 
can be noted; for example, Savic et al reported respiratory diseases (including infections), 199 
circulatory diseases and neoplasms as the leading causes of mortality for individuals who 200 
survived at least one year post-injury [13]. Additionally, in terms of direction and magnitude 201 
of the effect, differences exist between country-level comparisons of cause-specific SMRs. 202 
For example, in the United States, DeVivo et al reported a higher rate of cancer-related 203 
mortality among the SCI population compared to the GP, and reported SMRs nearly half that 204 
of what was estimated in this study for suicide [16]. In contrast, two studies from Estonia 205 
and Norway estimated similarly heighted suicide-specific SMRs compared with the present 206 
study [17,18]. Such differences could be impacted by incomplete and poorly informed coding 207 
practices of death certificates [19]. Age- and sex-specific mortality stratified by ICD-10 coding 208 
groups for the European standardized population could help improve comparability between 209 
countries, and thereby aid in benchmarking across health systems for chronic disease 210 
populations.  211 
Mortality rates between two- to three-times that of the GP have been regularly reported 212 
in recent SCI literature [3]. Unfortunately, despite advances in medical technology and 213 
rehabilitation, a multitude of studies have found only limited or no improvement in long-214 
term mortality [20,21]. The cause-specific SMR estimates reported in this study help identify 215 
potential causes that may be driving the overall mortality differential. For example, not only 216 
was cardiovascular disease the leading CoD, but also persons with SCI were found to have 217 
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about a 2.5 times greater risk of mortality due to cardiovascular disease in comparison with 218 
the GP. Modifications in cardiovascular disease risk post-SCI is likely related to physiologic 219 
changes associated with lesion level and severity. For example, immediately following SCI, 220 
the autonomic nervous system (ANS) incurs physiological alterations that have both acute 221 
and chronic implications on cardiovascular functioning, such as unstable blood pressure, 222 
autonomic dysreflexia (AD) and orthostatic hypotension (OH), associated with a multitude of 223 
cardiovascular complications, including cardiac arrest, intracranial hemorrhage, stroke and 224 
death [22]. Reflecting the influence of lesion characteristics on the risk of cardiovascular 225 
disease, autonomic dysreflexia – a response to stimuli below the lesion level characterized 226 
by an acute elevation of the systolic blood pressure – has been estimated to be three-times 227 
more common in individuals with complete tetraplegic lesions in comparison to individuals 228 
with incomplete lesions, with AD occurring primarily in high thoracic (paraplegic) and 229 
cervical (tetraplegic) lesions [22]. However, although pharmaceutical interventions and 230 
guidelines are available for management of AD, persons with SCI are still estimated to 231 
experience an average of 11 AD episodes per day [22], with episodes continuing to occur 232 
many years post-SCI [23]. The persistence of AD episodes as well as UTIs or pneumonia 233 
despite following the guidelines of best clinical practice and management, suggest the need 234 
for innovation in post-SCI care to improve long-term mortality outcomes [24].  235 
 236 
Strengths & limitations 237 
This study uses information from a large, nationally-representative cohort of persons 238 
admitted for first rehabilitation within a specialized SCI center in Switzerland, therefore 239 
study results are generalizable to other high-income rehabilitation settings. Unfortunately, 240 
some limitations exit. For example, many CoDs had small case numbers, thereby requiring 241 
caution when drawing conclusions from absolute numbers. Additionally, previous research 242 
has found that the CoD information coded on death certificates lacks reliability when 243 
identifying the true underlying CoD [25,26]. Assuming non-differential misclassification of 244 
codes between the GP and the TSCI population, for the present study, relative estimates of 245 
mortality would likely be attenuated towards the null, so over- or under-estimation of 246 
mortality differentials is unlikely. Another potential limitation of the current study was the 247 
use of probabilistic linkage to collect information on CoDs, and the resulting potential for 248 
incorrect linkages. However, a sensitivity analysis using secondary alternative links found no 249 
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meaningful influence on study results that would modify interpretation (Supplementary 250 
Table 4). Although unlinked deaths would bias absolute mortality rates, this study 251 
investigates relative mortality, for which unlinked deaths have been shown to have limited 252 
impact [27]. Finally, important targets for primary interventions include secondary health 253 
conditions – such as bladder control, pain, or pressure ulcers – which are notably missing 254 
from the present study. Currently, this information coupled with mortality outcomes is not 255 
available within the context of the Swiss SCI population.  256 
 257 
Conclusion 258 
The particularly elevated cause-specific SMRs reported within this study for cardiovascular 259 
diseases, urinary tract infections, and septicemia-related mortality require innovative 260 
approaches for management of SCI-associated secondary health conditions, as well as 261 
targeted interventions for known risk factors.  262 
 263 
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 379 
Table 1: Causes of death stratified by total, survival one year post-injury, and SCI characteristics  
  
  
Survival more than  
1 year post-injury 
Completeness of SCI 
[Missing=17] 
Level of SCI 
[Missing=1] 
Cause of death 
Total 
(N=335) 
Total 
(N=229) 
Incomplete Complete Tetraplegia Paraplegia 
Respiratory infection (J00-J22) 19 (5.7) 13 (5.7) 13 (6.2) 6 (5.6) 4 (2.9) 15 (8.3) 
Chronic obstructive pulmonary disease (J40-
J47) 
2 (0.6) 1 (0.4) 2 (0.9) - - 2 (1.1) 
Other respiratory disease (J30-J99) 19 (5.7) 10 (4.4) 7 (3.3) 11 (10.3) 8 (5.8) 11 (6.1) 
Cardiac disease (I05-I09; I11; I30-I59) 40 (11.9) 25 (10.9) 24 (11.4) 15 (14.0) 14 (10.1) 26 (14.4) 
Ischemic heart disease (I20-I25) 34 (10.1) 28 (12.2) 28 (13.3) 5 (4.7) 11 (7.9) 21 (11.6) 
Cerebral, circulatory disease (I60-I69) 13 (3.9) 11 (4.8) 10 (4.7) 2 (1.9) 3 (2.2) 9 (5.0) 
Pulmonary, circulatory disease (I26-I28) 16 (4.8) 9 (3.9) 9 (4.3) 7 (6.5) 7 (5.0) 9 (5.0) 
Other circulatory disease (I10; I12-I15; I70-
I99) 
19 (5.7) 12 (5.2) 11 (5.2) 7 (6.5) 12 (8.6) 7 (3.9) 
Neoplasms (C00-D49) 27 (8.1) 21 (9.2) 20 (9.5) 4 (3.7) 13 (9.4) 13 (7.2) 
Urinary infection (N390-N392) 7 (2.1) 7 (3.1) 4 (1.9) 3 (2.8) 4 (2.9) 3 (1.7) 
Renal failure (N17-N19) 2 (0.6) - 2 (0.9) - 1 (0.7) 1 (0.6) 
Digestive-related disease (K00-K95) 17 (5.1) 13 (5.7) 15 (7.1) 1 (0.9) 10 (7.2) 5 (2.8) 
Suicide (X71-X83) 21 (6.3) 18 (7.9) 14 (6.6) 7 (6.5) 12 (8.6) 5 (2.8) 
Accidents (S00-T88; V00-X58) 28 (8.4) 7 (3.1) 11 (5.2) 14 (13.1) 8 (5.8) 20 (11.0) 
Skin-related disease (L00-L99) 1 (0.3) 1 (0.4) - 1 (0.9) 1 (0.7) - 
Infectious disease (A00-B99, excl. A41) 4 (1.2) 3 (1.3) 2 (0.9) 2 (1.9) 3 (2.2) - 
Septicemia (A41) 7 (2.1) 5 (2.2) 4 (1.9) 3 (2.8) 3 (2.2) 4 (2.2) 
Ill-defined (R00-R99) 12 (3.6) 9 (3.9) 9 (4.3) 2 (1.9) 4 (2.9) 6 (3.3) 
Nervous System-related disease (G00-G99) 19 (5.7) 16 (7.0) 9 (4.3) 9 (8.4) 10 (7.2) 9 (5.0) 
Endocrine-related disease (E00-E89) 9 (2.7) 7 (3.1) 3 (1.4) 5 (4.7) 4 (2.9) 4 (2.2) 
Musculoskeletal-related disease (M00-M99) 7 (2.1) 4 (1.7) 7 (3.3) - 2 (1.4) 5 (2.8) 
Mental-related disease (F01-F99) 11 (3.3) 8 (3.5) 6 (2.8) 3 (2.8) 5 (3.6) 5 (2.8) 
Immune, blood, eye/ear-related disease  
(D50-D89; H00-H59) 
1 (0.3) 1 (0.4) 1 (0.5) - - 1 (0.6) 
 
Table 2: All-cause standardized mortality ratios (SMRs) 
 
  
Num. of 
deaths 
Expected 
deaths 
SMR  
(95% CI) 
Overall 376 162.19 2.32 (2.10-2.56) 
Sex 
Male 257 116.63 2.20 (1.95-2.49) 
Female 119 45.56 2.61 (2.18-3.13) 
Lesion Level* 
Paraplegia 156 76.71 2.03 (1.74-2.38) 
Tetraplegia 203 76.55 2.65 (2.31-3.04) 
Completeness* 
Incomplete 218 116.15 1.88 (1.64-2.14) 
Complete 125 32.42 3.86 (3.24-4.60) 
Level & completeness*       
Incomplete paraplegia 83 50.64 1.64 (1.32-2.03) 
Complete paraplegia 68 25.52 2.66 (2.10-3.38) 
Incomplete tetraplegia 135 65.53 2.06 (1.74-2.44) 
Complete tetraplegia 57 6.71 8.49 (6.55-11.01) 
Note: *Excluding cauda equina lesions 
 
Table 3: Cause-specific SMRs, overall and one year post-injury 
    Survived at least one year  
post-injury 
Causes of death 
Num. of 
deaths 
Expected 
deaths 
SMR (95% CI) 
Num. of 
deaths 
SMR (95% CI) 
Respiratory infection 19 3.12 6.10 (3.89-9.56) 13 4.29 (2.49-7.38) 
Chronic obstructive pulmonary disease 2 3.71 0.54 (0.13-2.16) 1 0.28 (0.04-1.95) 
Other respiratory disease 19 5.04 3.77 (2.41-5.91) 10 2.02 (1.09-3.75) 
Cardiac disease 40 10.62 3.77 (2.76-5.13) 25 2.41 (1.63-3.56) 
Ischemic heart disease 34 18.27 1.86 (1.33-2.60) 28 1.56 (1.08-2.27) 
Cerebral, circulatory disease 13 8.37 1.55 (0.90-2.67) 11 1.34 (0.74-2.42) 
Pulmonary, circulatory disease 16 0.88 18.15 (11.12-29.63) 9 10.38 (5.40-19.95) 
Other circulatory disease 19 7.21 2.50 (1.57-3.96) 12 1.70 (0.96-2.99) 
Neoplasms 27 38.37 0.70 (0.48-1.03) 21 0.56 (0.36-0.85) 
Urinary infection 7 0.39 18.16 (8.66-38.10) 7 18.54 (8.84-38.90) 
Renal failure 2 0.65 3.06 (0.77-12.25) 0 - 
Digestive disease 17 5.11 3.32 (2.07-5.35) 13 2.59 (1.50-4.45) 
Suicide 21 3.16 6.65 (4.34-10.20) 18 5.76 (3.63-9.14) 
Accidents 28 5.02 5.57 (3.85-8.07) 7 1.42 (0.67-2.97) 
Skin-related disease 1 0.17 5.88 (0.83-41.77) 1 6.00 (0.84-42.57) 
Infectious disease 4 1.54 2.59 (0.97-6.91) 3 1.97 (0.64-6.12) 
Septicemia 7 0.36 19.71 (9.40-41.35) 5 14.35 (5.97-34.46) 
Ill-defined 12 4.49 2.68 (1.52-4.71) 9 2.04 (1.06-3.92) 
Nervous system-related disease 19 5.77 3.29 (2.10-5.16) 16 2.82 (1.73-4.61) 
Endocrine-related disease 9 3.66 2.46 (1.28-4.72) 7 1.95 (0.93-4.08) 
Musculoskeletal-related disease 7 1.02 6.88 (3.28-14.43) 4 4.01 (1.50-10.67) 
Mental-related disease 11 6.28 1.75 (0.97-3.16) 8 1.30 (0.65-2.60) 
Immune, blood,   eye/ear-related disease 1 0.35 2.85 (0.40-20.27) 1 2.91 (0.41-20.65) 
 
 
 
Table 4: Cause-specific SMRs stratified by lesion characteristics 
  
Para Tetra Incomplete Complete 
Causes of death SMR (95% CI) SMR (95% CI) SMR (95% CI) SMR (95% CI) 
Respiratory infection 2.98 (1.12-7.94) 9.23 (5.57-15.32) 5.21 (3.03-8.98) 12.35 (5.55-27.50) 
Chronic obstructive pulmonary 
disease 
- 1.06 (0.27-4.24) 0.66 (0.17-2.65) - 
Other respiratory disease 3.58 (1.79-7.15) 4.33 (2.40-7.82) 1.71 (0.82-3.59) 14.12 (7.82-25.50) 
Cardiac disease 2.97 (1.76-5.02) 4.85 (3.30-7.13) 2.84 (1.90-4.24) 8.73 (5.26-14.48) 
Ischemic heart disease 1.35 (0.75-2.44) 2.30 (1.50-3.52) 1.91 (1.32-2.77) 1.72 (0.72-4.13) 
Cerebral, circulatory disease 0.81 (0.26-2.52) 2.12 (1.10-4.07) 1.50 (0.81-2.79) 1.47 (0.37-5.87) 
Pulmonary, circulatory disease 17.01 (8.11-35.68) 21.35 (11.11-41.03) 13.15 (6.84-25.26) 42.59 (20.30-89.34) 
Other circulatory disease 3.44 (1.90-6.20) 1.93 (0.92-4.05) 1.73 (0.93-3.21) 6.15 (2.93-12.91) 
Neoplasms 0.70 (0.41-1.21) 0.74 (0.43-1.28) 0.68 (0.44-1.05) 0.53 (0.20-1.40) 
Urinary infection 23.73 (8.90-63.21) 15.17 (4.89-47.03) 12.74 (4.78-33.95) 52.54 (16.94-162.89) 
Renal failure 3.42 (0.48-24.27) 3.07 (0.43-21.77) 3.76 (0.94-15.05) - 
Digestive disease 4.12 (2.22-7.65) 2.11 (0.88-5.06) 3.79 (2.28-6.28) 1.05 (0.15-7.42) 
Suicide 6.82 (3.87-12.01) 4.42 (1.84-10.61) 6.63 (3.92-11.19) 7.87 (3.75-16.50) 
Accidents 3.16 (1.58-6.31) 9.37 (6.04-14.52) 3.01 (1.67-5.43) 12.48 (7.39-21.07) 
Skin-related disease 12.93 (1.82-91.76) - - 34.50 (4.86-244.88) 
Infectious disease 3.90 (1.26-12.09) - 1.76 (0.44-7.03) 5.89 (1.47-23.54) 
Septicemia 18.54 (5.98-57.47) 23.04 (8.65-61.38) 14.20 (5.33-37.83) 50.09 (16.16-155.31) 
Ill-defined 1.86 (0.70-4.96) 2.92 (1.31-6.50) 2.61 (1.36-5.02) 2.31 (0.58-9.24) 
Nervous system-related disease 3.79 (2.04-7.04) 3.20 (1.66-6.15) 1.97 (1.03-3.79) 9.07 (4.72-17.42) 
Endocrine-related disease 2.36 (0.89-6.29) 2.27 (0.85-6.04) 1.05 (0.34-3.25) 7.65 (3.18-18.37) 
Musculoskeletal-related disease 4.30 (1.08-17.20) 10.04 (4.18-24.11) 8.78 (4.19-18.41) - 
Mental-related disease 1.74 (0.73-4.19) 1.64 (0.68-3.94) 1.21 (0.54-2.69) 2.81 (0.91-8.72) 
Immune, blood,   eye/ear-related 
disease 
- 5.96 (0.84-42.28) 3.68 (0.52-26.09) - 
Note: SMRs not calculated for those CoDs with insufficient cases.  
Table 5: Competing risk analysis of risk factors for cause-specific mortality, subhazard ratios 
  
Respiratory diseases 
(N=21) 
Cardiovascular diseases 
(N=122) 
Neoplasms 
(N=27) 
  Univariable Multivariable Univariable Multivariable Univariable Multivariable 
Age at injury             
Less than 46 
years 
Ref. Ref. Ref. Ref. Ref. Ref. 
46-60 years 6.59 (0.74-58.96) 5.07 (0.53-48.83) 2.63 (1.09-6.33) 2.48 (1.02-5.99) 5.67 (1.18-27.29) 3.56 (0.69-18.38) 
60 years and 
older 
28.94 (3.84-218.26) 
27.71 (3.62-
212.31) 
22.34 (10.86-45.94) 16.43 (7.87-34.31) 15.71 (3.63-68.01) 9.91 (2.24-43.78) 
Lesion Level 
      
Paraplegia Ref. Ref. Ref. Ref. Ref. Ref. 
Tetraplegia 2.60 (1.08-6.28) 3.37 (1.29-8.80) 2.58 (1.79-3.73) 2.22 (1.50-3.30) 1.68 (0.78-3.63) 1.45 (0.62-3.37) 
Completeness 
      
Incomplete Ref. Ref. Ref. Ref. Ref. Ref. 
Complete 2.25 (0.93-5.42) 4.95 (1.97-12.46) 0.78 (0.52-1.15) 1.50 (0.99-2.28) 0.36 (0.12-1.06) 0.55 (0.18-1.66) 
  
Infections 
(N=37) 
Accidents 
(N=28) 
Other 
(N=100) 
  Univariable Multivariable Univariable Multivariable Univariable Multivariable 
Age at injury             
Less than 46 
years 
Ref. Ref. Ref. Ref. Ref. Ref. 
46-60 years 0.69 (0.18-2.68) 0.67 (0.17-2.59) 1.43 (0.48-4.25) 1.38 (0.42-4.53) 1.44 (0.73-2.82) 1.16 (0.58-2.34) 
60 years and 
older 
6.87 (2.98-15.82) 5.53 (2.34-13.07) 3.74 (1.52-9.18) 3.57 (1.33-9.60) 5.75 (3.38-9.78) 4.31 (2.48-7.49) 
Lesion Level 
      
Paraplegia Ref. Ref. Ref. Ref. Ref. Ref. 
Tetraplegia 2.65 (1.35-5.17) 2.65 (1.32-5.34) 3.79 (1.67-8.60) 3.93 (1.65-9.37) 1.41 (0.93-2.14) 1.30 (0.83-2.02) 
Completeness 
      
Incomplete Ref. Ref. Ref. Ref. Ref. Ref. 
Complete 1.09 (0.56-2.13) 1.96 (0.96-4.00) 2.40 (1.09-5.30) 4.25 (1.86-9.72) 0.82 (0.52-1.29) 1.15 (0.72-1.84) 
Note: The group “Respiratory diseases” excludes respiratory infections, while the group “Infections” includes respiratory infections, septicemia, 
urinary tract infections, and all other infections. Sex and cause of TSCI were included in the analyses as potential confounders. 
Supplementary Table 1: Causes of death and associated SMRs according to decade, not using hierarchical coding scheme 
 
Causes of death 
Actual number 
of deaths 
Expected 
deaths 
SMR (95% 
Confidence Interval) 
Comparison 
with  
SMRs using 
heirarchy 
Respiratory infection 6 3.12 1.93 (0.87-4.29) ↓† 
Chronic obstructive pulmonary disease 1 3.71 0.27 (0.04-1.91) ‡↓ 
Other respiratory 7 5.04 1.39 (0.66-2.91) †↓ 
Cardiac disease 23 10.62 2.17 (1.44-3.26) ‡↓ 
Ischemic heart disease 30 18.27 1.64 (1.15-2.35) ‡↓ 
Cerebral, circulatory 13 8.37 1.55 (0.90-2.67) ‡ 
Pulmonary, circulatory 6 0.88 6.81 (3.06-15.15) ‡↓ 
Other circulatory 12 7.21 1.66 (0.94-2.93) †↓ 
Neoplasms 27 38.37 0.70 (0.48-1.03) ‡ 
Urinary infection 3 0.39 7.78 (2.51-24.13) ‡↓ 
Digestive 17 5.11 3.32 (2.07-5.35) ‡ 
Suicide 21 3.16 6.65 (4.34-10.20) ‡ 
Accidents 88 5.02 17.52 (14.22-21.59) ‡↑ 
Skin 1 0.17 5.88 (0.83-41.77) ‡ 
Infectious 4 1.54 2.59 (0.97-6.91) ‡ 
Septicemia 3 0.36 8.45 (2.72-26.20) ‡↓ 
Ill-defined 11 4.49 2.45 (1.36-4.43) ‡ 
Nervous 44 5.77 7.62 (5.67-10.24) ‡↑ 
Endocrine 5 3.66 1.36 (0.57-3.28) N.A. 
Musculoskeletal 5 1.02 4.91 (2.05-11.81) ‡↓ 
Mental 6 6.28 0.96 (0.43-2.13) ↓† 
Legend 
Increased ↑ 
Remained significant/non-significant ‡ 
Decreased ↓ 
No longer significant † 
 
Supplementary Table 2: Competing risk analysis of risk factors for respiratory infections, subhazard ratios  
 
  
Respiratory Infection All other causes 
  
Hierarchical coding 
(N=19) 
SA coding scheme 
(N=44) 
Hierarchical coding 
(N=316) 
SA coding scheme 
(N=291) 
Age at injury     
Less than 46 
years Ref. Ref. Ref. Ref. 
46-59 years 3.16 (0.21-47.55) 1.54 (0.49-4.83) 1.53 (1.23-1.90) 1.57 (1.28-1.92) 
60 years and older 21.65 (1.31-356.75) 16.89 (6.22-45.88) 7.17 (6.16-8.34) 6.78 (5.79-7.94) 
Lesion Level     
Paraplegia Ref. Ref. Ref. Ref. 
Tetraplegia 5.90 (2.35-14.76) 3.02 (1.12-8.17) 1.90 (1.46-2.47) 1.90 (1.42-2.52) 
Completeness     
Incomplete Ref. Ref. Ref. Ref. 
Complete 2.01 (1.34-3.04) 1.62 (1.06-2.47) 1.58 (1.26-1.98) 1.60 (1.28-2.00) 
 
* Notes: (1) "SA coding schema" refers to the identification of a "respiratory infection" ICD code anywhere on death certificate (i.e., underlying CoD, initial 
disease, consecutive, or concomitant). For example, individuals coded under the hierarchical coding schema as having died from a cardiovascular-related 
disease, but for which the respiratory infection code was included as a concomitant disease, would be included as having died due to a respiratory infection in the 
SA coding schema. (2) Cause of SCI and sex were also included within the multivariable models as potential confounders. 
Supplementary Table 3: Competing risk analysis of risk factors for UTI/renal failure, subhazard ratios 
 
  
Respiratory Infection All other causes 
  
Hierarchical coding 
(N=19) 
SA coding scheme 
(N=44) 
Hierarchical coding 
(N=316) 
SA coding scheme 
(N=291) 
Age at injury     
Less than 46 
years Ref. Ref. Ref. Ref. 
46-59 years 1.51 (1.30-1.75) 2.25 (2.06-2.47) 1.57 (1.23-2.00) 1.53 (1.21-1.94) 
60 years and older 10.46 (3.04-35.99) 14.87 (4.98-44.39) 7.44 (6.54-8.47) 7.15 (6.18-8.27) 
Lesion Level     
Paraplegia Ref. Ref. Ref. Ref. 
Tetraplegia 1.16 (0.39-3.44) 1.11 (0.48-2.56) 2.05 (1.57-2.69) 2.13 (1.59-2.86) 
Completeness     
Incomplete Ref. Ref. Ref. Ref. 
Complete 1.33 (0.55-3.21) 1.27 (0.66-2.45) 1.61 (1.27-2.04) 1.63 (1.24-2.15) 
 
* Notes: (1) "SA coding schema" refers to the identification of a UTI or renal failure ICD code anywhere on death certificate (i.e., underlying CoD, initial disease, 
consecutive, or concomitant). For example, individuals coded under the hierarchical coding schema as having died from a cardiovascular-related disease, but for 
which the renal failure code was included as a concomitant disease, would be included as having died due to UTI/renal failure in the SA coding schema. (2) 
Cause of SCI and sex were also included within the multivariable models as potential confounders. 
Supplementary Table 4: Causes of death and associated SMRs according to decade, alternative links 
Alternative link Primary link 
Causes of death 
Actual 
number of 
deaths 
Expected 
deaths 
SMR (95% 
Confidence 
Interval) 
SMR (95% Confidence 
Interval) 
Respiratory infection 17 3.12 5.46 (3.39-8.78) 6.10 (3.89-9.56) 
Chronic obstructive 
pulmonary disease 
3 3.71 0.81 (0.26-2.51) 0.54 (0.13-2.16) 
Other respiratory 19 5.04 3.77 (2.41-5.91) 3.77 (2.41-5.91) 
Cardiac disease 38 10.62 3.58 (2.60-4.92) 3.77 (2.76-5.13) 
Ischemic heart disease 34 18.27 1.86 (1.33-2.60) 1.86 (1.33-2.60) 
Cerebral, circulatory 12 8.37 1.43 (0.81-2.52) 1.55 (0.90-2.67) 
Pulmonary, circulatory 
15 0.88 
17.01 (10.26-
28.22) 
18.15 (11.12-29.63) 
Other circulatory 17 7.21 2.36 (1.47-3.79) 2.50 (1.57-3.96) 
Neoplasms 25 38.37 0.65 (0.44-0.96) 0.70 (0.48-1.03) 
Urinary infection 
7 0.39 
18.16 (8.66-
38.10) 
18.16 (8.66-38.10) 
Renal failure 2 0.65 3.06 (0.77-12.25) 3.06 (0.77-12.25) 
Digestive 17 5.11 3.32 (2.07-5.35) 3.32 (2.07-5.35) 
Suicide 20 3.16 6.34 (4.09-9.82) 6.65 (4.34-10.20) 
Accidents 25 5.02 4.98 (3.36-7.37) 5.57 (3.85-8.07) 
Skin 1 0.17 5.88 (0.83-41.77) 5.88 (0.83-41.77) 
Infectious 4 1.54 2.59 (0.97-6.91) 2.59 (0.97-6.91) 
Septicemia 
7 0.36 
19.71 (9.40-
41.35) 
19.71 (9.40-41.35) 
Ill-defined 12 4.49 2.68 (1.52-4.71) 2.68 (1.52-4.71) 
Nervous 18 5.77 3.12 (1.96-4.95) 3.29 (2.10-5.16) 
Endocrine 8 3.66 2.18 (1.09-4.37) 2.46 (1.28-4.72) 
Musculoskeletal 7 1.02 6.88 (3.28-14.43) 6.88 (3.28-14.43) 
Mental 12 6.28 1.91 (1.09-3.37) 1.75 (0.97-3.16) 
Immune, blood, eye/ear 1 0.35 2.85 (0.40-20.27) 2.85 (0.40-20.27) 
 
